Solventum Corporation (SOLV)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$1.57 (-2.19%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Solventum Corporation (SOLV)
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Key Insights

Critical company metrics and information
  • Share Price

    $70.11
  • Market Cap

    $12.11 Billion
  • Total Outstanding Shares

    172.75 Million Shares
  • Total Employees

    22,000
  • Dividend

    No dividend
  • IPO Date

    March 26, 2024
  • SIC Description

    Surgical & Medical Instruments & Apparatus
  • Homepage

    https://www.3m.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities$-202.00 Million
Net Cash Flow From Operating Activities$169.00 Million
Net Cash Flow From Investing Activities, Continuing$-93.00 Million
Net Cash Flow, Continuing$-126.00 Million
Net Cash Flow From Investing Activities$-93.00 Million
Net Cash Flow From Operating Activities, Continuing$169.00 Million
Net Cash Flow$-126.00 Million
Net Cash Flow From Financing Activities, Continuing$-202.00 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Income/Loss Attributable To Parent$122.00 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Operating Expenses$890.00 Million
Basic Average Shares$173.40 Million
Income Tax Expense/Benefit, Deferred$-37.00 Million
Gross Profit$1.17 Billion
Costs And Expenses$1.81 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Operating Income/Loss$275.00 Million
Income/Loss From Continuing Operations After Tax$122.00 Million
Income/Loss From Continuing Operations Before Tax$167.00 Million
Basic Earnings Per Share$0.70
Net Income/Loss Available To Common Stockholders, Basic$122.00 Million
Preferred Stock Dividends And Other Adjustments$0.00
Selling, General, and Administrative Expenses$701.00 Million
Income Tax Expense/Benefit$45.00 Million
Diluted Average Shares$173.90 Million
Net Income/Loss$122.00 Million
Revenues$2.08 Billion
Research and Development$189.00 Million
Diluted Earnings Per Share$0.70
Benefits Costs and Expenses$1.92 Billion
Cost Of Revenue$917.00 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Liabilities And Equity$14.74 Billion
Current Liabilities$2.90 Billion
Assets$14.74 Billion
Noncurrent Assets$11.39 Billion
Accounts Payable$560.00 Million
Other Non-current Assets$7.14 Billion
Current Assets$3.35 Billion
Other Current Liabilities$2.09 Billion
Equity Attributable To Noncontrolling Interest$0.00
Wages$251.00 Million
Inventory$953.00 Million
Intangible Assets$2.65 Billion
Equity$3.19 Billion
Other Non-current Liabilities$540.00 Million
Liabilities$11.55 Billion
Noncurrent Liabilities$8.65 Billion
Equity Attributable To Parent$3.19 Billion
Other Current Assets$2.40 Billion
Fixed Assets$1.60 Billion
Long-term Debt$8.11 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.